Metsera

Metsera EBITDA

Delisted

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Metsera (MTSR) as of Nov 4, 2026 is -224.83 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -43.67 M USD — a change of 414.86% (lower).

EBITDA

-224.83 MUSD

YoY

414.86%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Metsera is 2024 -224.83 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Metsera was 2023 -43.67 M USD. It decreases by 414.86% lower compared to the previous year.

The Metsera EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2022
-667,000.00 USD
Jan 1, 2023
-43.67 M USD
Jan 1, 2024
-224.83 M USD
The Metsera EBITDA history
YEAREBITDAYoY
-224.83 MUSD+414.86%
-43.67 MUSD+6,447.08%
-667,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Metsera Stock analysis

What does Metsera do? Metsera Inc. is a clinical stage biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on Biotechnology. The company develops next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for treating obesity and related conditions. Utilizing its proprietary MINT peptide library, HALO half-life extension platform, and MOMENTUM oral delivery system, Metsera has a pipeline including MET-097i, MET-233i, and MET-224o, targeting various obesity treatments with differentiated approaches. Listed on 31 January 2025, the company employs 82 staff. Metsera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Metsera stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Metsera is -224.83 M USD in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Metsera changed from -43.67 M USD to -224.83 M USD, representing a 414.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Metsera since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Metsera historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Metsera

All Key Metrics — Metsera